SEC Form 4 · accession 0001127602-16-058004
Medtronic plc · MDT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gary Lee Ellis
Officer — EVP & Global Ops and IT
Period of report
Jul 13, 2016
Accepted (ET)
Jul 14, 2016 · 4:40 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001613103
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Jul 13, 2016 | M | 41,068 | $48.70 | A | 216,434 | D | |
| Ordinary SharesF2 | Jul 13, 2016 | S | 35,495 | $88.638 | D | 180,939 | D | |
| Ordinary Shares | holding | — | — | — | 5,234 | I | 401(k) | |
| Ordinary Shares | holding | — | — | — | 7,851 | I | Esop |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3 | $48.70 | Jul 13, 2016 | M | 41,068 | D | — | Oct 30, 2016 | Ordinary Shares | 41,068 | 0 | D |
Explanation of responses
- F1This balance increased by 1,345 shares due to exempt transactions such as dividend reinvestment.
- F2The price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.60 to $88.7734, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes to this Form 4.
- F3This option to purchase 41,068 New Medtronic ordinary shares for $48.70 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 41,068 Medtronic common stock shares for $48.70 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.